Who Paid My Doc
Christina Samathanam
Anatomic Pathology & Clinical Pathology Reno, NV Medical Doctor
NPI 1427069863 CMS profile 1257266
1664 North Virginia Street, Mail Stop 350, Reno, NV 89557
General payments
$844,578
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Christina Samathanam of Reno, NV is reported in the CMS Open Payments database as having received $844,578 across 593 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Anatomic Pathology & Clinical Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $164,624 | 90 | |
| 2024 | General | $400,657 | 190 | |
| 2023 | General | $139,207 | 127 | |
| 2022 | General | $83,906 | 107 | |
| 2021 | General | $48,795 | 74 | |
| 2020 | General | $7,389 | 5 |
Beside peers
- Christina Samathanam
- Anatomic Pathology & Clinical Pathology median
- Middle half of Anatomic Pathology & Clinical Pathology
- National median
In program year 2025, general payments to Christina Samathanam were reported at $164,624. Among 2,804 Anatomic Pathology & Clinical Pathology profiles paid that year, the median was $51 and the middle half received between $24 and $149.
Show as a table
| Year | Christina Samathanam | Anatomic Pathology & Clinical Pathology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $65 | $22–$150 | $163 |
| 2020 | $7,389 | $44 | $19–$144 | $114 |
| 2021 | $48,795 | $42 | $19–$142 | $132 |
| 2022 | $83,906 | $54 | $20–$140 | $149 |
| 2023 | $139,207 | $60 | $23–$157 | $160 |
| 2024 | $400,657 | $51 | $23–$145 | $164 |
| 2025 | $164,624 | $51 | $24–$149 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
11
Drug cost
$11
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Metformin Hcl | Generic | 11 | $11 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 205 Part D prescribers listed as Pathology; they describe a distribution and say nothing about conduct.
Records
593 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Anatomic Pathology & Clinical Pathology in Nevada
Jamie Shutter
Anatomic Pathology & Clinical Pathology · Las Vegas, NV
Hala Abdelaziz
Anatomic Pathology & Clinical Pathology · Las Vegas, NV
Damanzoopinder Samrao
Anatomic Pathology & Clinical Pathology · Las Vegas, NV
Jonathan Hughes
Anatomic Pathology & Clinical Pathology · Las Vegas, NV
Ronald Knoblock
Anatomic Pathology & Clinical Pathology · Las Vegas, NV
June Sigman
Anatomic Pathology & Clinical Pathology · Las Vegas, NV
Related records
Anatomic Pathology & Clinical Pathology in Nevada
Practitioners in the same specialty and state, ranked by reported value.
All Anatomic Pathology & Clinical Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Nevada
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.